These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 32507039)

  • 1. Effects of Ramipril on the Aldosterone/Renin Ratio and the Aldosterone/Angiotensin II Ratio in Patients With Primary Aldosteronism.
    Guo Z; Poglitsch M; Cowley D; Domenig O; McWhinney BC; Ungerer JPJ; Wolley M; Stowasser M
    Hypertension; 2020 Aug; 76(2):488-496. PubMed ID: 32507039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of Equilibrium Angiotensin II in the Diagnosis of Primary Aldosteronism.
    Guo Z; Poglitsch M; McWhinney BC; Ungerer JPJ; Ahmed AH; Gordon RD; Wolley M; Stowasser M
    Clin Chem; 2020 Mar; 66(3):483-492. PubMed ID: 32068832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
    Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interruption of prolonged ramipril treatment in hypertensive patients: effects on the renin-angiotensin system.
    Stephan D; Grima M; Welsch M; Barthelmebs M; Vasmant D; Imbs J
    Fundam Clin Pharmacol; 1996; 10(5):474-83. PubMed ID: 8902551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives.
    Lamarre-Cliche M; de Champlain J; Lacourcière Y; Poirier L; Karas M; Larochelle P
    Am J Hypertens; 2005 Jan; 18(1):56-64. PubMed ID: 15691618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study.
    Rossi GP; Ceolotto G; Rossitto G; Maiolino G; Cesari M; Seccia TM
    J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32067030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between screening for primary aldosteronism with and without drug adjustment.
    Hua Y; He Q
    Blood Press; 2024 May; 33(1):2350981. PubMed ID: 38824645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism.
    Jansen PM; van den Born BJ; Frenkel WJ; de Bruijne EL; Deinum J; Kerstens MN; Smulders YM; Woittiez AJ; Wijbenga JA; Zietse R; Danser AH; van den Meiracker AH
    J Hypertens; 2014 Jan; 32(1):115-26. PubMed ID: 24018605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroidomics-Based Screening for Primary Aldosteronism: Impact of antihypertensive Drugs.
    Constantinescu G; Gruber S; Fuld S; Peitzsch M; Schulze M; Remde H; Kürzinger L; Yang J; Yen T; Williams TA; Müller L; Reincke M; Lenders JWM; Beuschlein F; Pamporaki C; Eisenhofer GF
    Hypertension; 2024 Oct; 81(10):2060-2071. PubMed ID: 39082132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin-Angiotensin-Aldosterone System Triple-A Analysis for the Screening of Primary Aldosteronism.
    Burrello J; Buffolo F; Domenig O; Tetti M; Pecori A; Monticone S; Poglitsch M; Mulatero P
    Hypertension; 2020 Jan; 75(1):163-172. PubMed ID: 31760886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sodium-glucose cotransporter-2 inhibitors on aldosterone-to-renin ratio in diabetic patients with hypertension: a retrospective observational study.
    Sawamura T; Karashima S; Nagase S; Nambo H; Shimizu E; Higashitani T; Aono D; Ohbatake A; Kometani M; Demura M; Furukawa K; Takeda Y; Yoneda T
    BMC Endocr Disord; 2020 Nov; 20(1):177. PubMed ID: 33256676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of LC-MS/MS aldosterone and automated direct renin in screening for primary aldosteronism.
    Juutilainen A; Savolainen K; Romppanen J; Turpeinen U; Hämäläinen E; Kemppainen J; Moilanen L; Pulkki K
    Clin Chim Acta; 2014 Jun; 433():209-15. PubMed ID: 24661979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism.
    Mulatero P; Rabbia F; Milan A; Paglieri C; Morello F; Chiandussi L; Veglio F
    Hypertension; 2002 Dec; 40(6):897-902. PubMed ID: 12468576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of dietary salt intake on aldosterone and the aldosterone-to-renin ratio as screening parameters for primary aldosteronism.
    Koch M; Aker S; Haastert B; Rump LC
    Clin Nephrol; 2010 Sep; 74(3):182-9. PubMed ID: 20860902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary aldosteronism: Aldosterone/renin ratio cut-off points.
    Eugenio Russmann ML; Delfino L; Fierro F; Santoro S; Peréz M; Caruso G; Glikman P; Gauna A; Lupi S
    Endocrinol Diabetes Nutr (Engl Ed); 2019; 66(6):361-367. PubMed ID: 30737120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Criteria for diagnosing primary aldosteronism on the basis of liquid chromatography-tandem mass spectrometry determinations of plasma aldosterone concentration.
    Baron S; Amar L; Faucon AL; Blanchard A; Baffalie L; Faucard C; Travers S; Pagny JY; Azizi M; Houillier P
    J Hypertens; 2018 Jul; 36(7):1592-1601. PubMed ID: 29677048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
    Seifarth C; Trenkel S; Schobel H; Hahn EG; Hensen J
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):457-65. PubMed ID: 12354127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High efficiency of the aldosterone-to-renin ratio in precisely detecting primary aldosteronism.
    Gan W; Lin W; Ouyang J; Li Y; Chen D; Yao Z; Feng P
    J Hum Hypertens; 2019 Jan; 33(1):57-61. PubMed ID: 30242245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension.
    Browne GA; Griffin TP; O'Shea PM; Dennedy MC
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):325-31. PubMed ID: 26300226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal tissue angiotensins during converting enzyme inhibition in the spontaneously hypertensive rat.
    Grima M; Ingert C; Michel B; Barthelmebs M; Imbs JL
    Clin Exp Hypertens; 1997; 19(5-6):671-85. PubMed ID: 9247747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.